Listed

Mesabi Trust

MSBNYSECIK 65172FinancialsFiscal year ends Jan 31

Latest reported revenue, Q2 FY2026$2.5mRevenue, Q2 FY2026, three months to 2026-07-31$2.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Report this figureThree months to Jul 31, 2026, from the 10-Q filed Sep 11, 2026.

Latest quarter: Q2 FY2026

Three months to Jul 31, 2026, against the same quarter a year earlier.

  • Revenue$2.5mRevenue, Q2 FY2026, three months to 2026-07-31$2.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Report this figure−55.8% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
  • Net margin−3.8%Net margin, Q2 FY2026, three months to 2026-07-31. net income / revenueNet income: −$95.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Revenue: $2.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Report this figure−88.4 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$2.5mNet margin −3.8%
Mesabi Trust, key figures for the last eight quarters
Line itemUnitQ2 FY20232024-07-31Q3 FY20232024-10-31Q4 FY20242025-01-31Q1 FY20252025-04-30Q2 FY20252025-07-31Q3 FY20252025-10-31Q1 FY20262026-04-30Q2 FY20262026-07-31Shape over the periods
Revenue$m6.5Revenue, Q2 FY2023, three months to 2024-07-31$6.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-09-15, accession 0001104659-25-090029.Report this figure79.0Revenue, Q3 FY2023, three months to 2024-10-31$79.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-12, accession 0001104659-25-120673.Report this figure6.9Revenue, Q4 FY2024, three months to 2025-01-31$6.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-24, accession 0001558370-25-005426. Derived: 12-month figure less the 9-month figure.Report this figure4.7Revenue, Q1 FY2025, three months to 2025-04-30$4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-06-12, accession 0001104659-26-073470.Report this figure5.6Revenue, Q2 FY2025, three months to 2025-07-31$5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Report this figure3.6Revenue, Q3 FY2025, three months to 2025-10-31$3.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-12, accession 0001104659-25-120673.Report this figure2.2Revenue, Q1 FY2026, three months to 2026-04-30$2.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-06-12, accession 0001104659-26-073470.Report this figure2.5Revenue, Q2 FY2026, three months to 2026-07-31$2.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%83.2%Net margin, Q2 FY2023, three months to 2024-07-31. net income / revenueNet income: $5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-09-15, accession 0001104659-25-090029.Revenue: $6.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-09-15, accession 0001104659-25-090029.Report this figure99.1%Net margin, Q3 FY2023, three months to 2024-10-31. net income / revenueNet income: $78.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-12, accession 0001104659-25-120673.Revenue: $79.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-12, accession 0001104659-25-120673.Report this figure88.5%Net margin, Q4 FY2024, three months to 2025-01-31. net income / revenueNet income: $6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-24, accession 0001558370-25-005426. Derived: 12-month figure less the 9-month figure.Revenue: $6.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-24, accession 0001558370-25-005426. Derived: 12-month figure less the 9-month figure.Report this figure76.7%Net margin, Q1 FY2025, three months to 2025-04-30. net income / revenueNet income: $3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-06-12, accession 0001104659-26-073470.Revenue: $4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-06-12, accession 0001104659-26-073470.Report this figure84.6%Net margin, Q2 FY2025, three months to 2025-07-31. net income / revenueNet income: $4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Report this figure77.1%Net margin, Q3 FY2025, three months to 2025-10-31. net income / revenueNet income: $2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-12, accession 0001104659-25-120673.Revenue: $3.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-12-12, accession 0001104659-25-120673.Report this figure48.4%Net margin, Q1 FY2026, three months to 2026-04-30. net income / revenueNet income: $1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-06-12, accession 0001104659-26-073470.Revenue: $2.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-06-12, accession 0001104659-26-073470.Report this figure(3.8%)Net margin, Q2 FY2026, three months to 2026-07-31. net income / revenueNet income: −$95.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Revenue: $2.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-09-11, accession 0001104659-26-107085.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$98.6mNet margin 94.6%
Mesabi Trust, key figures for the last five fiscal years
Line itemUnitFY20202021-01-31FY20212022-01-31FY20222023-01-31FY20232024-01-31FY20242025-01-31Shape over the periods
Revenue$m26.0Revenue, FY2020, twelve months to 2021-01-31$26.0m. XBRL concept us-gaap:Revenues. 10-K filed 2023-04-24, accession 0001558370-23-006525.Report this figure71.5Revenue, FY2021, twelve months to 2022-01-31$71.5m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-24, accession 0001558370-24-005598.Report this figure7.7Revenue, FY2022, twelve months to 2023-01-31$7.7m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-24, accession 0001558370-24-005598.Report this figure22.9Revenue, FY2023, twelve months to 2024-01-31$22.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-24, accession 0001558370-25-005426.Report this figure98.6Revenue, FY2024, twelve months to 2025-01-31$98.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-24, accession 0001558370-25-005426.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%90.2%Net margin, FY2020, twelve months to 2021-01-31. net income / revenueNet income: $23.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-04-24, accession 0001558370-23-006525.Revenue: $26.0m. XBRL concept us-gaap:Revenues. 10-K filed 2023-04-24, accession 0001558370-23-006525.Report this figure96.2%Net margin, FY2021, twelve months to 2022-01-31. net income / revenueNet income: $68.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-04-24, accession 0001558370-24-005598.Revenue: $71.5m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-24, accession 0001558370-24-005598.Report this figure68.6%Net margin, FY2022, twelve months to 2023-01-31. net income / revenueNet income: $5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-04-24, accession 0001558370-24-005598.Revenue: $7.7m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-24, accession 0001558370-24-005598.Report this figure83.0%Net margin, FY2023, twelve months to 2024-01-31. net income / revenueNet income: $19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-24, accession 0001558370-25-005426.Revenue: $22.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-24, accession 0001558370-25-005426.Report this figure94.6%Net margin, FY2024, twelve months to 2025-01-31. net income / revenueNet income: $93.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-24, accession 0001558370-25-005426.Revenue: $98.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-24, accession 0001558370-25-005426.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Mesabi Trust
FundQuarter endedReported valueSharesPut or callChange on the quarter before
HORIZON KINETICS ASSET MANAGEMENT LLC2026-06-30$81.5m3,219,382Added+78,410
VALUEWORKS LLC2026-06-30$16.9m669,733Added+23,151
CWA Asset Management Group, LLC2026-06-30$13.1m518,974Added+71,489
FIRST MANHATTAN CO. LLC.2026-06-30$10.0m396,373Added+86,313
MAD RIVER INVESTORS2026-06-30$8.2m323,735Added+2,189
Advisory Services Network, LLC2026-06-30$4.7m185,669Added+1,040
Moors & Cabot, Inc.2026-06-30$4.5m178,289Reduced−2,656
EagleClaw Capital Managment, LLC2026-06-30$4.3m170,575Added+800
MORGAN STANLEY2026-06-30$2.9m113,293Reduced−752
Bank of New York Mellon Corp2026-06-30$2.6m101,464Added+1,266

Recent filings

All 257 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Mesabi Trust, recent filings
FiledFormWhat it isAccession number
2026-10-1520:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-116264
2026-09-1120:30 ET10-QQuarterly reportPeriod 2026-07-310001104659-26-107085
2026-07-3120:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0001104659-26-089248
2026-07-1420:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-083538
2026-06-1220:15 ET10-QQuarterly reportPeriod 2026-04-300001104659-26-073470
2026-05-0420:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-054941
2026-04-2220:30 ET10-KAnnual reportPeriod 2026-01-310001104659-26-046864
2026-04-1420:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-043216
2026-02-0321:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0001104659-26-009757
2026-01-1621:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-004561

Latest annual report

Form 10-K for the fiscal year ended Jan 31, 2026Filed Apr 22, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
65172
Tickers
MSB
Exchange
NYSE
SIC code
6795 Mineral Royalty Traders
Sector
Financials
Fiscal year ends
Jan 31
Incorporated in
NY
Filer category
Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. Listed shows no prices and gives no investment advice.